Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
Home
Conference Coverage
ASH
ASH
Highlights from ASH: Conversations with Christopher Heery and Srdan Verstovsek
Danielle Garcia
-
April 15, 2023
Highlights from ASH: Conversations about Multiple Myeloma with Thomas Martin and Monica Soni
Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patient with B-lineage ALL
Blood Thinners During Pregnancy in Women with Recurrent Miscarriage and Inherited Thrombophilia
Zanubrutinib Demonstrates Superior PFS versus Ibrutinib in Patients Diagnosed with r/r CLL or SLL
Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® in R/R AML
Editorial Team
-
December 12, 2022
A First in Class Investigational CXCR1/2 inhibitor Demonstrates Single-agent Efficacy in MDS
Danielle Garcia
-
December 12, 2022
New Anti-mutant Calreticulin (CALR)-targeted mAb: An Important Research Milestone in MF and ET
Danielle Garcia
-
December 11, 2022
Combination Treatments in Patients with Myeloproliferative Neoplasms Reduce Burden of Disease
Danielle Garcia
-
December 10, 2022
ASH 2022: Positive OS Data for Patients in R/R AML in Phase 1 Actimab-A...
Danielle Garcia
-
November 3, 2022
Insights from ASH: Treating Myeloma Is a Marathon, Not a Sprint
Robert M. Rifkin, MD, FACP
-
May 5, 2022
LATEST NEWS
Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery
Peter Hofland
-
November 25, 2023
Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?
Editorial Team
-
November 24, 2023
Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments
Brandon H. McNaughton, Ph.D.
-
November 23, 2023
Activating Bitter Taste Receptors May Kill Certain Cancer Cells
Editorial Team
-
November 22, 2023
GRP78 – A Promising Target for CAR T-cells Helps Cancer Trick the Immune System
Editorial Team
-
November 21, 2023
X